Registry for patients with structural ventricular arrhythmias in China
China Structural Ventricular Arrhythmias Registry, a Multicenter，Observational and Prospective Study.
China National Center for Cardiovascular Diseases · NCT03821051
This study is trying to find out how common serious heart rhythm problems are in China and what factors might increase the risk for people with these conditions by collecting health information from 2000 participants.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | China National Center for Cardiovascular Diseases (other gov) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT03821051 on ClinicalTrials.gov |
What this trial studies
This observational, prospective, multi-center registry aims to build a risk stratification for malignant structural ventricular arrhythmias by recruiting 2000 participants from 10 major arrhythmia centers across China. Participants will have their clinical data abstracted from medical records and blood samples collected to identify promising risk indicators. Follow-ups will occur every six months to monitor the condition of arrhythmia and related clinical events. The study seeks to clarify the prevalence and risk factors associated with these arrhythmias in the Chinese population.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with ventricular arrhythmias resulting from structural heart diseases such as ischemic cardiomyopathy or dilated cardiomyopathy.
Not a fit: Patients without a definitive diagnosis of ventricular arrhythmia or those with arrhythmias not related to structural heart diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and early prevention strategies for patients with malignant ventricular arrhythmias.
How similar studies have performed: Other studies focusing on risk stratification for ventricular arrhythmias have shown promise, but this specific registry approach is novel in the Chinese context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosed as ventricular arrhythmia resulted by structural heart diseases, including ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc. Exclusion Criteria: * none
Where this trial is running
Beijing, Beijing Municipality
- China National Center for Cardiovascular Diseases — Beijing, Beijing Municipality, China (RECRUITING)
Study contacts
- Study coordinator: Yan Yao, MD,PhD
- Email: ianyao@263.net.cn
- Phone: +86-13901121319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Ventricular Arrythmia, structural ventricular arrythmia, ischemic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, risk stratification